Structures by: Ananth K. M.
Total: 4
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl benzoate
C20H19N3O4S
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=6.75590(10)Å b=16.9258(2)Å c=19.0611(3)Å
α=110.4470(10)° β=96.854(2)° γ=93.3700(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl isobutyrate 0.25-hydrate
C17H21N3O4S,0.25(H2O)
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=6.78020(10)Å b=17.2671(4)Å c=17.3089(4)Å
α=108.2240(10)° β=99.0840(10)° γ=96.7200(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl propionate
C16H19N3O4S
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=11.4150(3)Å b=12.4021(3)Å c=13.2305(3)Å
α=71.9820(10)° β=89.8290(10)° γ=83.1140(10)°
4-(5-Acetamido-3-acetyl-2-methyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)phenyl cinnamate chloroform hemisolvate
C22H21N3O4S,0.5(CHCl3)
Acta Crystallographica Section E (2019) 75, 10 1436-1444
a=10.74270(10)Å b=11.0828(2)Å c=20.8969(3)Å
α=93.1860(10)° β=103.945(4)° γ=98.489(2)°